🧬 SinoBioData Academic Portal
Official PDF TranslationChinese Journal of Tissue Engineering Research

Single-dose liposomal bupivacaine versus continuous ropivacaine infusion for adductor canal block analgesia after total knee arthroplasty

Authors: LIU Chenglong; WEI Shanwen; LI Di; ZOU Mingming; MA Yanxia

DOI: 10.12307/2026.21392Status: Verified Translated Edition
Sponsored AdvertisementAd Placement Area
reCAPTCHA Bot Shield Active

Preparing Secure Academic Download

Verifying human reader & generating high-resolution document...

Verifying Document Integrity15s remaining
← Back to Article
Protected by Google reCAPTCHA v3.PrivacyTerms
Sponsored ContentAdSense In-Feed Ad Slot

Key Findings in This Report

• Single-dose liposomal bupivacaine provides comparable analgesia to continuous ropivacaine infusion for 72 hours after total knee arthroplasty. • Single-dose liposomal bupivacaine significantly reduces procedure time (6.1 vs 20.3 minutes) and cost (saving 132 RMB per patient). • No significant differences in pain scores, morphine consumption, hospital stay, or patient satisfaction between the two techniques. • Single-dose liposomal bupivacaine avoids catheter-related complications and is a more efficient, cost-effective alternative.
Download Full PDF: Single-dose liposomal bupivacaine versus continuous ropivacaine infusion for adductor canal block analgesia after total knee arthroplasty | SinoBioData | SinoBioData